Mild Vaginal Dysplasia (VaIN 1 / Vaginal LSIL): The Case for Observation as First-Line Management
Mild vaginal dysplasia — classified as low-grade vaginal squamous intraepithelial lesion (vaginal LSIL) or VaIN 1, including HPV-associated changes — sits at the lowest-grade end of vaginal intraepithelial neoplasia. Deciding whether to intervene or observe is the central clinical question at this grade.
Clinical context
At this grade of dysplasia, the evidence base distinguishes clearly between low-grade (VaIN 1) and high-grade (VaIN 2–3) lesions. For low-grade disease, current evidence does not support a benefit from immediate treatment over a structured follow-up approach.
Management — partial overview
Expectant management (observation) is a recognised, evidence-supported strategy for this grade of lesion. The full structured regimen — covering follow-up parameters, criteria for escalation, and the complete clinical algorithm — is available via the protocol below.
References
DOI: 10.1136/ijgc-2022-004213
- VaIN 1 (low grade vaginal SIL) can be subjected to follow-up, while VaIN 2–3 (high-grade vaginal SIL) should be treated.
- There is evidence that treatment does not lead to better clinical outcomes in patients with VaIN 1.
- As such, low grade lesions can be safely managed by observation.
View source ↗